Our new findings relating CR1 expression to progression from MCI to AD dementia provide further validation of that previous work and argue for greater focus on CR1—and on genetic variation in MCI-to-AD progression more broadly49—to enable better understanding of the mechanisms underlying AD and its clinical trajectories. This evidence concerns the gene CR1 and dementia.